UGT1A1*28 POLYMORPHISM AND THE RISK OF TOXICITY AND DISEASE PROGRESSION IN PATIENTS WITH BREAST CANCER RECEIVING SACITUZUMAB GOVITECAN. Novembre 18, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
CHARACTERISTICS AND CLINICAL OUTCOMES OF BREAST CANCER IN YOUNG BRCA CARRIERS ACCORDING TO TUMOR HISTOLOGY Novembre 10, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
15 GENNAIO 2024, VERONA AIGOM-GIST AVANZATI: IL VALORE DELLA GESTIONE MULTIDISCIPLINARE DEL PAZIENTE Novembre 9, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME/da Luisa
NEOADJUVANT CHEMOTHERAPY WITH OXALIPLATIN AND FLUOROPYRIMIDINE VERSUS UPFRONT SURGERY FOR LOCALLY ADVANCED COLON CANCER: THE RANDOMIZED, PHASE III OPTICAL TRIAL. Novembre 5, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
NEOADJUVANT DOCETAXEL, OXALIPLATIN, AND S-1 PLUS SURGERY AND ADJUVANT S-1 FOR RESECTABLE ADVANCED GASTRIC CANCER: UPDATED OVERALL SURVIVAL OUTCOMES FROM PHASE III PRODIGY. Ottobre 28, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
ELACESTRANT (ORAL SELECTIVE ESTROGEN RECEPTOR DEGRADER) VERSUS STANDARD ENDOCRINE THERAPY FOR ESTROGEN RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED BREAST CANCER: RESULTS FROM THE RANDOMIZED PHASE III EMERALD TRIAL. Ottobre 21, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
TRASTUZUMAB DERUXTECAN AFTER ENDOCRINE THERAPY IN METASTATIC BREAST CANCER. Ottobre 14, 2024/0 Commenti/in ARTICOLI SCIENTIFICI, NEWS, NEWS IN HOME/da Luisa
AICRO-MENTI A CONTATTO 8 NOVEMBRE 2024 ROMA-MILANO Ottobre 10, 2024/0 Commenti/in EVENTI, NEWS, NEWS IN HOME, PATROCINIO/da Luisa
